Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Inozyme Pharma Q3 EPS $(0.60) Up From $(1.55) YoY

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.60) per share. This is a 61.29 percent increase over losses of $(1.55) per share from the same period last year.
byBenzinga Newsdesk
November 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.60) per share. This is a 61.29 percent increase over losses of $(1.55) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: DHT Holdings

By Benzinga Insights
Today, 5:58 AM
DHT Holdings (NYSE:DHT) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that DHT Holdings will report an earnings per share (EPS) of $-0.01.

DHT